Huntington National Bank’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $478K | Buy |
2,607
+160
| +7% | +$29.5K | ﹤0.01% | 637 |
|
|
2025
Q4 | $431K | Buy |
2,447
+162
| +7% | +$26.5K | ﹤0.01% | 584 |
|
|
2025
Q3 | $320K | Buy |
2,285
+235
| +11% | +$31.8K | ﹤0.01% | 650 |
|
|
2025
Q2 | $257K | Sell |
2,050
-383
| -16% | -$47.7K | ﹤0.01% | 687 |
|
|
2025
Q1 | $333K | Buy |
2,433
+19
| +0.8% | +$2.72K | ﹤0.01% | 601 |
|
|
2024
Q4 | $369K | Buy |
2,414
+106
| +5% | +$17.9K | ﹤0.01% | 572 |
|
|
2024
Q3 | $447K | Buy |
2,308
+79
| +4% | +$16.5K | ﹤0.01% | 540 |
|
|
2024
Q2 | $517K | Buy |
2,229
+52
| +2% | +$11.3K | ﹤0.01% | 492 |
|
|
2024
Q1 | $469K | Sell |
2,177
-126
| -5% | -$29.5K | ﹤0.01% | 501 |
|
|
2023
Q4 | $596K | Sell |
2,303
-319
| -12% | -$78.4K | 0.01% | 458 |
|
|
2023
Q3 | $674K | Sell |
2,622
-6
| -0.2% | -$1.6K | 0.01% | 434 |
|
|
2023
Q2 | $749K | Buy |
2,628
+135
| +5% | +$40.2K | 0.01% | 425 |
|
|
2023
Q1 | $693K | Buy |
2,493
+24
| +1% | +$6.64K | 0.01% | 430 |
|
|
2022
Q4 | $684K | Sell |
2,469
-1,527
| -38% | -$431K | 0.01% | 426 |
|
|
2022
Q3 | $1.07M | Sell |
3,996
-157
| -4% | -$33.3K | 0.01% | 360 |
|
|
2022
Q2 | $847K | Buy |
4,153
+1,530
| +58% | +$313K | 0.01% | 392 |
|
|
2022
Q1 | $552K | Buy |
2,623
+5
| +0.2% | +$1.09K | 0.01% | 470 |
|
|
2021
Q4 | $628K | Sell |
2,618
-161
| -6% | -$41.4K | 0.01% | 455 |
|
|
2021
Q3 | $787K | Sell |
2,779
-21
| -0.8% | -$6.88K | 0.01% | 408 |
|
|
2021
Q2 | $970K | Buy |
2,800
+1,319
| +89% | +$400K | 0.01% | 381 |
|
|
2021
Q1 | $414K | Buy |
1,481
+61
| +4% | +$16.5K | 0.01% | 421 |
|
|
2020
Q4 | $348K | Sell |
1,420
-6
| -0.4% | -$1.55K | ﹤0.01% | 429 |
|
|
2020
Q3 | $405K | Sell |
1,426
-22
| -2% | -$6.14K | 0.01% | 396 |
|
|
2020
Q2 | $388K | Sell |
1,448
-292
| -17% | -$87.8K | 0.01% | 401 |
|
|
2020
Q1 | $551K | Sell |
1,740
-154
| -8% | -$46.7K | 0.01% | 343 |
|
|
2019
Q4 | $562K | Buy |
1,894
+163
| +9% | +$45.2K | 0.01% | 385 |
|
|
2019
Q3 | $403K | Sell |
1,731
-408
| -19% | -$95K | 0.01% | 412 |
|
|
2019
Q2 | $500K | Sell |
2,139
-245
| -10% | -$56.6K | 0.01% | 389 |
|
|
2019
Q1 | $563K | Sell |
2,384
-80
| -3% | -$25.2K | 0.01% | 370 |
|
|
2018
Q4 | $741K | Sell |
2,464
-316
| -11% | -$101K | 0.01% | 353 |
|
|
2018
Q3 | $982K | Buy |
2,780
+376
| +16% | +$129K | 0.02% | 345 |
|
|
2018
Q2 | $698K | Sell |
2,404
-76
| -3% | -$21.4K | 0.01% | 382 |
|
|
2018
Q1 | $679K | Sell |
2,480
-156
| -6% | -$48.4K | 0.01% | 388 |
|
|
2017
Q4 | $840K | Sell |
2,636
-63
| -2% | -$20.2K | 0.01% | 376 |
|
|
2017
Q3 | $845K | Sell |
2,699
-241
| -8% | -$71.4K | 0.01% | 376 |
|
|
2017
Q2 | $798K | Sell |
2,940
-67
| -2% | -$17.7K | 0.01% | 382 |
|
|
2017
Q1 | $822K | Buy |
3,007
+76
| +3% | +$21.5K | 0.01% | 389 |
|
|
2016
Q4 | $831K | Sell |
2,931
-29
| -1% | -$8.6K | 0.02% | 380 |
|
|
2016
Q3 | $928K | Buy |
2,960
+359
| +14% | +$106K | 0.02% | 361 |
|
|
2016
Q2 | $629K | Buy |
2,601
+570
| +28% | +$150K | 0.02% | 352 |
|
|
2016
Q1 | $857K | Sell |
2,031
-777
| -28% | -$205K | 0.02% | 368 |
|
|
2015
Q4 | $860K | Buy |
2,808
+91
| +3% | +$26.1K | 0.02% | 337 |
|
|
2015
Q3 | $793K | Buy |
2,717
+350
| +15% | +$116K | 0.02% | 353 |
|
|
2015
Q2 | $957K | Buy |
2,367
+336
| +17% | +$135K | 0.02% | 335 |
|
|
2015
Q1 | $857K | Buy |
2,031
+30
| +1% | +$11.8K | 0.02% | 369 |
|
|
2014
Q4 | $679K | Sell |
2,001
-1,039
| -34% | -$336K | 0.02% | 390 |
|
|
2014
Q3 | $1M | Sell |
3,040
-392
| -11% | -$129K | 0.02% | 514 |
|
|
2014
Q2 | $1.08M | Sell |
3,432
-1,169
| -25% | -$352K | 0.02% | 544 |
|
|
2014
Q1 | $1.41M | Buy |
4,601
+2,036
| +79% | +$646K | 0.03% | 509 |
|
|
2013
Q4 | $717K | Sell |
2,565
-57
| -2% | -$14.7K | 0.02% | 386 |
|
|
2013
Q3 | $631K | Sell |
2,622
-169
| -6% | -$37.8K | 0.02% | 387 |
|
|
2013
Q2 | $600K | Buy |
+2,791
| New | +$596K | 0.02% | 392 |
|
Other funds holding BIIB
VCM
VPM
Huntington National Bank's BIIB Position: Q1 2026 in Review
Huntington National Bank increased its Biogen (BIIB) stake by 6.5% in Q1 2026, buying an estimated $29.5K and bringing the position to 2,607 shares worth $478K. The position accounts for ﹤0.01% of the portfolio, ranked #637.
Huntington National Bank first reported a position in BIIB in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.41M in Q1 2014. 1,004 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Huntington National Bank held 2,607 shares of Biogen worth $478K as of Q1 2026.
- Huntington National Bank bought 160 Biogen shares in Q1 2026, an estimated $29.5K.
- Biogen made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #637 holding.
- Huntington National Bank first reported a position in Biogen in Q2 2013 and has held it in 52 quarters since.
- Huntington National Bank's Biogen position peaked at $1.41M in Q1 2014.
- 1,004 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.